{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:01:50Z","timestamp":1789628510245,"version":"build-2803163510"},"reference-count":92,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,21]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">LINC01615<\/jats:italic>\n                      , a long noncoding RNA, plays a pivotal role in the progression of kidney renal clear cell carcinoma (KIRC). This study aimed to assess the prognostic value of\n                      <jats:italic toggle=\"yes\">LINC01615<\/jats:italic>\n                      -associated genes in KIRC by developing a risk model. Differential expression analysis in the The Cancer Genome Atlas-KIRC dataset identified differentially expressed genes between high and low\n                      <jats:italic toggle=\"yes\">LINC01615<\/jats:italic>\n                      expression groups, as well as between KIRC and control groups. Signature genes were subsequently selected through protein-protein interaction (PPI) network analysis, while prognostic genes were identified\n                      <jats:italic toggle=\"yes\">via<\/jats:italic>\n                      Cox regression. The risk model was then constructed and validated using the E-MTAB-1980 dataset. Furthermore, an independent prognostic analysis identified key risk factors, and a nomogram was created for clinical application. Additional analyses, including enrichment analysis, immune-related analysis, drug sensitivity evaluation, and regulatory network construction, were performed to explore the underlying mechanisms in high and low-risk groups. The GSE40435 dataset was employed for the validation of prognostic gene expression. Reverse transcription-quantitative PCR (RT-qPCR) was conducted to confirm the expression levels of prognostic genes and\n                      <jats:italic toggle=\"yes\">LINC01615<\/jats:italic>\n                      in clinical samples.\n                      <jats:italic toggle=\"yes\">LINC01615<\/jats:italic>\n                      expression was found to differ significantly between KIRC and control groups, with notable survival differences observed between high and low expression groups. A total of 757 candidate genes were identified. Among these,\n                      <jats:italic toggle=\"yes\">COL4A4<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">COL5A1<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">COL15A1<\/jats:italic>\n                      were screened as prognostic genes, and a risk model with better accuracy was constructed. Age and risk score were recognized as independent risk factors, and the nomogram demonstrated enhanced predictive accuracy. Twelve drugs showed a significant negative correlation with risk scores. Additionally, the high-risk group exhibited an increased likelihood of immune escape. A regulatory relationship between hsa-miR-3163 and\n                      <jats:italic toggle=\"yes\">COL4A4<\/jats:italic>\n                      \/\n                      <jats:italic toggle=\"yes\">LINC01615<\/jats:italic>\n                      was identified. In both The Cancer Genome Atlas-KIRC and GSE40435 datasets,\n                      <jats:italic toggle=\"yes\">COL5A1<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">COL15A1<\/jats:italic>\n                      were overexpressed in the KIRC group. RT-qPCR results for\n                      <jats:italic toggle=\"yes\">COL5A1<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">COL4A4<\/jats:italic>\n                      were consistent with the above findings, while\n                      <jats:italic toggle=\"yes\">COL15A1<\/jats:italic>\n                      showed no significant differences in clinical samples, possibly due to the small sample size.\n                      <jats:italic toggle=\"yes\">COL4A4<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">COL5A1<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">COL15A1<\/jats:italic>\n                      were identified as prognostic biomarkers through bioinformatics analysis. The developed risk model offers valuable insights for clinical prognostic prediction and immunotherapy in KIRC.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050176","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:06:50Z","timestamp":1787332010000},"page":"e50176","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic and immunological value of LINC01615-related genes in kidney clear cell carcinoma"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7810-2072","authenticated-orcid":false,"given":"Shijie","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Urology, the First Affiliated Hospital of Hainan Medical University, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangqin","family":"Xu","sequence":"additional","affiliation":[{"name":"Emergency Department, the First Affiliated Hospital of Hainan Medical University, Hainan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Urology, the First Affiliated Hospital of Hainan Medical University, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinshan","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Urology, the First Affiliated Hospital of Hainan Medical University, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, the First Affiliated Hospital of Hainan Medical University, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wengui","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Urology, the First Affiliated Hospital of Hainan Medical University, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6615-0376","authenticated-orcid":false,"given":"Yubin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, the First Affiliated Hospital of Hainan Medical University, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260917","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260917","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma.","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20260917","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","article-title":"Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.","volume":"17","author":"Jonasch","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"R4-20260917","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/cells13010034","article-title":"Emerging immunotherapy approaches for advanced clear cell renal cell carcinoma.","volume":"13","author":"Meng","year":"2023","journal-title":"Cells"},{"key":"R5-20260917","first-page":"17","article-title":"Cancer statistics, 2023.","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R6-20260917","doi-asserted-by":"crossref","first-page":"165","DOI":"10.21037\/atm.2018.04.44","article-title":"Survival outcomes for advanced kidney cancer patients in the era of targeted therapies.","volume":"6","author":"Rao","year":"2018","journal-title":"Ann Transl Med"},{"key":"R7-20260917","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","article-title":"Functional classification and experimental dissection of long noncoding RNAs.","volume":"172","author":"Kopp","year":"2018","journal-title":"Cell"},{"key":"R8-20260917","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-biochem-051410-092902","article-title":"Genome regulation by long noncoding RNAs.","volume":"81","author":"Rinn","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"R9-20260917","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature20149","article-title":"Local regulation of gene expression by lncRNA promoters, transcription and splicing.","volume":"539","author":"Engreitz","year":"2016","journal-title":"Nature"},{"key":"R10-20260917","first-page":"7253","article-title":"Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p\/GSK3\u03b2 pathway in ovarian cancer.","volume":"24","author":"Zhu","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R11-20260917","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41420-021-00790-9","article-title":"Long non-coding RNA LINC00511 facilitates colon cancer development through regulating microRNA-625-5p to target WEE1.","volume":"8","author":"Qian","year":"2022","journal-title":"Cell Death Discov"},{"key":"R12-20260917","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The role of non-coding RNAs in oncology.","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"key":"R13-20260917","doi-asserted-by":"crossref","first-page":"17781","DOI":"10.1007\/s00432-023-05476-6","article-title":"Construction of an EMT-related lncRNA prognostic signature for lung adenocarcinoma and functional verification of its hub gene LINC01615.","volume":"149","author":"Shan","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"R14-20260917","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.3390\/cancers14194815","article-title":"SIPA1 regulates LINC01615 to promote metastasis in triple-negative breast cancer.","volume":"14","author":"Xiang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R15-20260917","doi-asserted-by":"crossref","first-page":"12964","DOI":"10.1002\/jcp.27963","article-title":"Identification of LINC01615 as potential metastasis-related long noncoding RNA in hepatocellular carcinoma.","volume":"234","author":"Ji","year":"2019","journal-title":"J Cell Physiol"},{"key":"R16-20260917","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/15384101.2021.2015670","article-title":"LINC01615 activates ZEB2 through competitively binding with miR-3653-3p to promote the carcinogenesis of colon cancer cells.","volume":"21","author":"Hu","year":"2022","journal-title":"Cell Cycle"},{"key":"R17-20260917","doi-asserted-by":"crossref","first-page":"787884","DOI":"10.3389\/fgene.2022.787884","article-title":"Identification and validation of a ferroptosis-related long non-coding RNA (FRlncRNA) signature to predict survival outcomes and the immune microenvironment in patients with clear cell renal cell carcinoma.","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Genet"},{"key":"R18-20260917","doi-asserted-by":"crossref","first-page":"682002","DOI":"10.3389\/fcell.2021.682002","article-title":"Identification of CDK2-related immune forecast model and ceRNA in lung adenocarcinoma, a pan-cancer analysis.","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R19-20260917","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/jso.27358","article-title":"Clinicopathological characteristics of pheochromocytoma\/paraganglioma and screening of prognostic markers.","volume":"128","author":"Lei","year":"2023","journal-title":"J Surg Oncol"},{"key":"R20-20260917","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker.","volume":"56","author":"Heagerty","year":"2000","journal-title":"Biometrics"},{"key":"R21-20260917","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"R22-20260917","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","article-title":"ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2.","volume":"38","author":"Gustavsson","year":"2022","journal-title":"Bioinformatics"},{"key":"R23-20260917","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","article-title":"circlize Implements and enhances circular visualization in R.","volume":"30","author":"Gu","year":"2014","journal-title":"Bioinformatics"},{"key":"R24-20260917","doi-asserted-by":"crossref","first-page":"e4865","DOI":"10.1002\/nbm.4865","article-title":"Visualizing metabolomics data with R.","volume":"36","author":"Berker","year":"2023","journal-title":"NMR Biomed"},{"key":"R25-20260917","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters.","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"R26-20260917","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12967-020-02689-y","article-title":"Three hematologic\/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis.","volume":"19","author":"Cheng","year":"2021","journal-title":"J Transl Med"},{"key":"R27-20260917","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1109\/TVCG.2017.2743959","article-title":"Bubble treemaps for uncertainty visualization.","volume":"24","author":"Gortler","year":"2018","journal-title":"IEEE Trans Vis Comput Graph"},{"key":"R28-20260917","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"R29-20260917","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent.","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"R30-20260917","doi-asserted-by":"crossref","first-page":"2","DOI":"10.18637\/jss.v079.c02","article-title":"plotROC: a tool for plotting ROC curves.","volume":"79","author":"Sachs","year":"2017","journal-title":"J Stat Softw"},{"key":"R31-20260917","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection.","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"R32-20260917","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade.","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"key":"R33-20260917","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"R34-20260917","first-page":"135","article-title":"Translation and adaptation of the adult developmental coordination disorder\/dyspraxia checklist (ADC) into Asian Uzbekistan.","volume":"11","author":"Orifjon","year":"2023","journal-title":"Sports (Basel)"},{"key":"R35-20260917","doi-asserted-by":"crossref","first-page":"989286","DOI":"10.3389\/fimmu.2022.989286","article-title":"Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"R36-20260917","first-page":"3143511","article-title":"A novel necroptosis-associated lncRNA signature can impact the immune status and predict the outcome of breast cancer.","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Immunol Res"},{"key":"R37-20260917","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"R38-20260917","doi-asserted-by":"crossref","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","article-title":"OncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data.","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief Bioinform"},{"key":"R39-20260917","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","article-title":"European Association of Urology guidelines on renal cell carcinoma: the 2019 update.","volume":"75","author":"Ljungberg","year":"2019","journal-title":"Eur Urol"},{"key":"R40-20260917","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1208\/s12248-024-00990-y","article-title":"Precision nanomedicine: lapatinib-loaded chitosan-gold nanoparticles targeting LINC01615 for lung cancer therapy.","volume":"27","author":"Rezaei Aghdam","year":"2024","journal-title":"AAPS J"},{"key":"R41-20260917","doi-asserted-by":"crossref","first-page":"818306","DOI":"10.3389\/fgene.2022.818306","article-title":"Establishment and validation of a ferroptosis-related long non-coding RNA signature for predicting the prognosis of stomach adenocarcinoma.","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Genet"},{"key":"R42-20260917","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1093\/ndt\/gfp158","article-title":"Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3\/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis.","volume":"24","author":"Pierides","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R43-20260917","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1681\/ASN.2021111447","article-title":"Genetic variants of the COL4A3, COL4A4, and COL4A5 genes contribute to thinned glomerular basement membrane lesions in sporadic IgA nephropathy patients.","volume":"34","author":"Yuan","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"R44-20260917","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3390\/vaccines9121510","article-title":"A five collagen-related gene signature to estimate the prognosis and immune microenvironment in clear cell renal cell cancer.","volume":"9","author":"Shi","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"R45-20260917","doi-asserted-by":"crossref","first-page":"994208","DOI":"10.3389\/fgene.2022.994208","article-title":"A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma.","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Genet"},{"key":"R46-20260917","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1249\/MSS.0b013e3181f34f4d","article-title":"The COL5A1 gene: a novel marker of endurance running performance.","volume":"43","author":"Posthumus","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"R47-20260917","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41388-024-03030-3","article-title":"COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk.","volume":"43","author":"Chen","year":"2024","journal-title":"Oncogene"},{"key":"R48-20260917","doi-asserted-by":"crossref","first-page":"752694","DOI":"10.3389\/fonc.2021.752694","article-title":"COL5A1 serves as a biomarker of tumor progression and poor prognosis and may be a potential therapeutic target in gliomas.","volume":"11","author":"Gu","year":"2021","journal-title":"Front Oncol"},{"key":"R49-20260917","doi-asserted-by":"crossref","first-page":"8624","DOI":"10.1002\/cam4.3472","article-title":"Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.","volume":"9","author":"Lin","year":"2020","journal-title":"Cancer Med"},{"key":"R50-20260917","doi-asserted-by":"crossref","first-page":"933241","DOI":"10.3389\/fimmu.2022.933241","article-title":"Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma.","volume":"13","author":"Cai","year":"2022","journal-title":"Front Immunol"},{"key":"R51-20260917","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2147\/CMAR.S188216","article-title":"Overexpression of COL5A1 promotes tumor progression and metastasis and correlates with poor survival of patients with clear cell renal cell carcinoma.","volume":"11","author":"Feng","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R52-20260917","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/CIRCRESAHA.110.222133","article-title":"Collagen XV is necessary for modeling of the extracellular matrix and its deficiency predisposes to cardiomyopathy.","volume":"107","author":"Rasi","year":"2010","journal-title":"Circ Res"},{"key":"R53-20260917","doi-asserted-by":"crossref","first-page":"9978","DOI":"10.3390\/ijms22189978","article-title":"Deletion of Col15a1 modulates the tumour extracellular matrix and leads to increased tumour growth in the MMTV-PyMT mouse mammary carcinoma model.","volume":"22","author":"Mart\u00ednez-Nieto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R54-20260917","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbrc.2023.09.031","article-title":"COL15A1 interacts with P4HB to regulate the growth and malignancy of HepG2.2.15 cells.","volume":"681","author":"Wang","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"key":"R55-20260917","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12672-024-01200-z","article-title":"Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker.","volume":"15","author":"Zhu","year":"2024","journal-title":"Discov Oncol"},{"key":"R56-20260917","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/bs.ctdb.2018.02.005","article-title":"Basement membranes in development and disease.","volume":"130","author":"Sekiguchi","year":"2018","journal-title":"Curr Top Dev Biol"},{"key":"R57-20260917","doi-asserted-by":"crossref","first-page":"147850","DOI":"10.1016\/j.gene.2023.147850","article-title":"Chitosan inhibits vascular intimal hyperplasia via LINC01615\/MIR-185-5p\/PIK3R2 signaling pathway.","volume":"892","author":"Yan","year":"2024","journal-title":"Gene"},{"key":"R58-20260917","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yjmcc.2021.12.011","article-title":"MiR-185-5p regulates the development of myocardial fibrosis.","volume":"165","author":"Lin","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"R59-20260917","doi-asserted-by":"crossref","first-page":"1326026","DOI":"10.3389\/fimmu.2024.1326026","article-title":"Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy.","volume":"15","author":"Duan","year":"2024","journal-title":"Front Immunol"},{"key":"R60-20260917","doi-asserted-by":"crossref","first-page":"469.e19","DOI":"10.1016\/j.urolonc.2025.02.016","article-title":"Transcriptomic and proteo-metabolic determinants of the grading system in clear cell renal cell carcinoma.","volume":"43","author":"Lucarelli","year":"2025","journal-title":"Urol Oncol"},{"key":"R61-20260917","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/14737159.2023.2195553","article-title":"The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery.","volume":"23","author":"di Meo","year":"2023","journal-title":"Expert Rev Mol Diagn"},{"key":"R62-20260917","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/14737159.2019.1607729","article-title":"Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma.","volume":"19","author":"Lucarelli","year":"2019","journal-title":"Expert Rev Mol Diagn"},{"key":"R63-20260917","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/1873-3468.14531","article-title":"The cross-talk between Abl2 tyrosine kinase and TGF\u03b21 signalling modulates the invasion of clear cell renal cell carcinoma cells.","volume":"597","author":"De Marco","year":"2023","journal-title":"FEBS Lett"},{"key":"R64-20260917","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.18632\/aging.101685","article-title":"Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemo resistance, and mitochondrial dysfunction in clear cell renal cell carcinoma.","volume":"10","author":"Lucarelli","year":"2018","journal-title":"Aging (Milano)"},{"key":"R65-20260917","doi-asserted-by":"crossref","first-page":"113502","DOI":"10.18632\/oncotarget.23056","article-title":"The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation.","volume":"8","author":"Bianchi","year":"2017","journal-title":"Oncotarget"},{"key":"R66-20260917","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/diseases4010007","article-title":"Renal cell carcinoma: a study through NMR-based metabolomics combined with transcriptomics.","volume":"4","author":"Ragone","year":"2016","journal-title":"Diseases"},{"key":"R67-20260917","doi-asserted-by":"crossref","first-page":"13968","DOI":"10.3390\/ijms232213968","article-title":"MUC1 tissue expression and its soluble form CA15-3 identify a clear cell renal cell carcinoma with distinct metabolic profile and poor clinical outcome.","volume":"23","author":"Lucarelli","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R68-20260917","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10238-026-02042-5","article-title":"MUC1\/CA15-3 identifies a clear cell renal carcinoma characterized by Sunitinib response with a specific metabolic signature.","volume":"26","author":"Lucarelli","year":"2026","journal-title":"Clin Exp Med"},{"key":"R69-20260917","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11934-026-01325-4","article-title":"Sarcomatoid renal cell carcinoma: biological features and therapeutic implications-a narrative review.","volume":"27","author":"Lasorsa","year":"2026","journal-title":"Curr Urol Rep"},{"key":"R70-20260917","doi-asserted-by":"crossref","first-page":"13179","DOI":"10.3390\/ijms241713179","article-title":"Cancer stem cells in renal cell carcinoma: origins and biomarkers.","volume":"24","author":"Lasorsa","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R71-20260917","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/cells14100717","article-title":"The Metabolic landscape of cancer stem cells: insights and implications for therapy.","volume":"14","author":"Milella","year":"2025","journal-title":"Cells"},{"key":"R72-20260917","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.18632\/aging.103169","article-title":"PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma.","volume":"12","author":"Netti","year":"2020","journal-title":"Aging (Milano)"},{"key":"R73-20260917","doi-asserted-by":"crossref","first-page":"461.e15","DOI":"10.1016\/j.urolonc.2017.02.011","article-title":"Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma.","volume":"35","author":"Lucarelli","year":"2017","journal-title":"Urol Oncol"},{"key":"R74-20260917","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-0039-1688495","article-title":"Fibrin and fibrinolysis in cancer.","volume":"45","author":"Kwaan","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"R75-20260917","doi-asserted-by":"crossref","first-page":"101774","DOI":"10.1016\/j.tranon.2023.101774","article-title":"Fatty acid metabolism-related genes as a novel module biomarker for kidney renal clear cell carcinoma: bioinformatics modeling with experimental verification.","volume":"38","author":"Jia","year":"2023","journal-title":"Transl Oncol"},{"key":"R76-20260917","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/MCB.00879-12","article-title":"Ribosomal protein S25 dependency reveals a common mechanism for diverse internal ribosome entry sites and ribosome shunting.","volume":"33","author":"Hertz","year":"2013","journal-title":"Mol Cell Biol"},{"key":"R77-20260917","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1038\/onc.2012.289","article-title":"Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop.","volume":"32","author":"Zhang","year":"2013","journal-title":"Oncogene"},{"key":"R78-20260917","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12920-024-01934-3","article-title":"Comprehensive analysis of the expression, prognostic, and immune infiltration for COL4s in stomach adenocarcinoma.","volume":"17","author":"Xu","year":"2024","journal-title":"BMC Med Genomics"},{"key":"R79-20260917","doi-asserted-by":"crossref","first-page":"6419695","DOI":"10.1155\/2022\/6419695","article-title":"The hypoxia-related gene COL5A1 Is a prognostic and immunological biomarker for multiple human tumors.","volume":"2022","author":"Zhu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"R80-20260917","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1158\/2159-8290.CD-19-0499","article-title":"Tumor microenvironment dynamics in clear-cell renal cell carcinoma.","volume":"9","author":"Vuong","year":"2019","journal-title":"Cancer Discovery"},{"key":"R81-20260917","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12967-016-0841-9","article-title":"miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction.","volume":"14","author":"Gigante","year":"2016","journal-title":"J Transl Med"},{"key":"R82-20260917","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/biomedicines11041071","article-title":"Immune checkpoint inhibitors in renal cell carcinoma: molecular basis and rationale for their use in clinical practice.","volume":"11","author":"Lasorsa","year":"2023","journal-title":"Biomedicines"},{"key":"R83-20260917","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.3390\/cancers12123574","article-title":"Metabolomics to assess response to immune checkpoint inhibitors in patients with non-small-cell lung cancer.","volume":"12","author":"Ghini","year":"2020","journal-title":"Cancers"},{"key":"R84-20260917","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.3390\/jcm12123888","article-title":"Cellular and molecular players in the tumor microenvironment of renal cell carcinoma.","volume":"12","author":"Lasorsa","year":"2023","journal-title":"J Clin Med"},{"key":"R85-20260917","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/cancers18030414","article-title":"Molecular remodeling of peritumoral tissue in clear cell renal cell carcinoma: insights into inflammation and prognostic markers.","volume":"18","author":"Netti","year":"2026","journal-title":"Cancers"},{"key":"R86-20260917","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1158\/1535-7163.MCT-08-0492","article-title":"AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies.","volume":"7","author":"Zabludoff","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"R87-20260917","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12935-019-0896-9","article-title":"Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells.","volume":"19","author":"Zhu","year":"2019","journal-title":"Cancer Cell Int"},{"key":"R88-20260917","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-016-0473-1","article-title":"Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine.","volume":"36","author":"Isono","year":"2017","journal-title":"J Experimental Clin Cancer Res"},{"key":"R89-20260917","doi-asserted-by":"crossref","first-page":"e14272","DOI":"10.1016\/j.heliyon.2023.e14272","article-title":"Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer-associated macrophages.","volume":"9","author":"Hu","year":"2023","journal-title":"Heliyon"},{"key":"R90-20260917","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1007\/s12013-024-01463-x","article-title":"Iron overloading potentiates the antitumor activity of 5-fluorouracil by promoting apoptosis and Ferro ptosis in colorectal cancer cells.","volume":"82","author":"Rah","year":"2024","journal-title":"Cell Biochem Biophys"},{"key":"R91-20260917","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/0115680096321287240826065718","article-title":"Screening miRNAs to hinder the tumorigenesis of renal clear cell carcinoma associated with KDR expression.","volume":"25","author":"Kaviyaprabha","year":"2025","journal-title":"Curr Cancer Drug Targets"},{"key":"R92-20260917","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00280-014-2380-5","article-title":"Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors.","volume":"73","author":"Sausville","year":"2014","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:01:56Z","timestamp":1789624916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050176"}},"subtitle":["Integrated bioinformatics analysis and expression validation"],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":92,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050176","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"2025-07-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}